Tag: Mylan Launches Generic Aromasin® Tablets
Mylan Launches Generic Aromasin® Tablets
Mylan Launches Generic Aromasin® Tablets
HERTFORDSHIRE, England and PITTSBURGH, March 13, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference...